How non-invasive TM Flow System testing helps physicians gather critical diagnostic data safely, with less patient discomfort and risk, to optimize care.
Small fiber neuropathy is common and underdiagnosed. Why early detection matters and how the TM Flow System’s sudomotor testing finds it in a routine visit.
Why physicians should prioritize balance testing: how the vestibular system affects dizziness and falls, and what a VAT ENG test shows.
Vestibular testing belongs in every fall prevention plan for older adults. What VAT ENG testing measures and how it helps physicians reduce fall injuries.
Peripheral neuropathy affects millions of Americans. Symptoms, causes and how in-office TM Flow System testing supports earlier evaluation and treatment.
PAD is a terrible condition that impacts millions every year. We are doing our best to spread awareness and educate people about the dangers of PAD.
PAD is projected to affect 19 million Americans by 2050 and is most common after 65. How the TM Flow System’s ABI testing helps catch it early in the office.
What the Ankle Brachial Index (ABI) measures, why an abnormal ABI points to peripheral artery disease, and how the TM Flow System runs ABI testing in-office.
15-19 million Americans have peripheral arterial disease. How the TM Flow System’s non-invasive in-office ABI testing identifies PAD in three billable tests.
The TM Flow System performs three billable diagnostic tests in one non-invasive office visit: sudomotor (small fiber neuropathy), ABI and ANS.
